OPKO Health, Inc. (NASDAQ:OPK) is now up 24.44% compared to a 12-month low of $2.66. We have seen the price to move -6.76% lower and get settled at $3.31 on 03/13/2018. At recent session, it appeared stuck in a range of $3.3 to $3.57. This company shares are 259.52% off its target price of $11.9 and the current market capitalization stands at $1.71B. The recent change has given its price a -22.07% deficit over SMA 50 and -61.24% deficit over its 52-week high. The stock witnessed -14.69% declines, -36.95% declines and -46.7% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found OPK’s volatility during a week at 6.73% and during a month it has been found around 6.59%.OPKO Health, Inc. (OPK) Top Holders
Institutional investors currently hold around $464 million or 24.1% in OPK stock. Look at its top three institutional owners. Vanguard Group Inc owns $98.24 million in OPKO Health, Inc., which represents roughly 5.75% of the company’s market cap and approximately 21.17% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 21,886,055 shares of the stock are valued at $77.7 million. The third largest holder is State Street Corp, which currently holds $50 million worth of this stock and that ownership represents nearly 2.92% of its market capitalization.
At the end of 12/31/2017 reporting period, 101 institutional holders increased their position in OPKO Health, Inc. (NASDAQ:OPK) by some 10,296,855 shares, 118 decreased positions by 10,816,809 and 49 held positions by 109,726,419. That puts total institutional holdings at 130,840,083 shares, according to SEC filings. The stock grabbed 39 new institutional investments totaling 1,868,161 shares while 42 institutional investors sold out their entire positions totaling 2,744,995 shares.OPKO Health, Inc. (NASDAQ:OPK) Insider Trades
Multiple company employees have indulged in significant insider trading. OPKO Health, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that CEO & Chairman, 10% Owner Frost Phillip Md Et Al has acquired 25,000 shares of OPKO Health, Inc. (OPK) in trading session dated Mar. 12, 2018. These shares are worth $87,000 and were traded at $3.48 each. The SEC filing shows that Frost Phillip Md Et Al performed a purchase of 32,000 shares. The CEO & Chairman, 10% Owner added these shares by way of transaction on Mar. 08, 2018. The company’s shares were assimilated at $3.28 per share worth to an investment of some $104,960 on account of Frost Phillip Md Et Al.
Executive VP-Administration, Rubin Steven D, purchased 6,000 common shares of OPKO Health, Inc. (OPK) in the open market. In a transaction dated Mar. 07, 2018, the shares were bought at an average price of $3.25, giving away a sum of $19,500. After this purchase, 25,782,977 common shares of OPK are directly owned by the insider, with total stake valued at $85,341,654.
In the transaction dated Mar. 07, 2018, the great number of shares acquired came courtesy the CEO & Chairman, 10% Owner; Frost Phillip Md Et Al added a total of 75,000 shares at an average price of $3.29, amounting to approximately $246,750. The insider now directly owns 189,344,756 shares worth $626,731,142.OPKO Health, Inc. (OPK) Analyst Guide
Several analysts have released their opinion on OPKO Health, Inc. (NASDAQ:OPK), with 4 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 1 strong sell ratings, collectively assigning a 2 average brokerage recommendation.